J Clin Pathways. 2018;4(3):26-29.
NCCN presented its 23rd Annual Conference in Orlando, Florida. The conference—which focuses on improving the quality, effectiveness, and efficiency of cancer care—hosts over 1600 national and international academic and community oncologists, oncology fellows, nurses, pharmacists, and other health care professionals involved in cancer care.
Presentations and roundtable discussions featured key update summaries of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and how these updates impact and integrate into cancer management strategies. Another key topic at this year’s conference included issues related to patients receiving CAR T-cell therapy immunotherapy.
Journal of Clinical Pathways was on-site in order to provide in-depth coverage of the keynote sessions and other relevant conversations at the conference.
Early Data Show Positive Trend in OCM Cost Savings
Ron Kline, MD, FAAP, gave an overview of the OCM and an unofficial preview of the preliminary data CMMI has accrued from OCM practices within the first 6 months of implementation.
The Current Landscape of Managed Care: Where We Are, and Where We Could Go
The second presentation was given by Lee N Newcomer, MD, MHA, former senior vice president, Oncology and Genetics, United Healthcare, a leading voice in the payer community, who spoke on cancer care delivery from the managed care perspective.
Multidisciplinary Roundtable Discussion Focuses on Emerging Issues in Value-Based Health Care Models
A lively roundtable discussion took place on the NCCN stage regarding critical current and emerging issues in the delivery of cancer care in value-based care models.
Supportive Care Deemed Critical in NCCN Updated Guidelines for Multiple Myeloma
The NCCN treatment guidelines for multiple myeloma still promote the use of supportive care as a critical component of care.